sulfinpyrazone has been researched along with practolol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Schröder, R | 1 |
Smith, JW | 1 |
Pentecost, BL | 1 |
Lown, B; Raeder, EA; Verrier, RL | 1 |
1 review(s) available for sulfinpyrazone and practolol
Article | Year |
---|---|
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors | 1981 |
1 trial(s) available for sulfinpyrazone and practolol
Article | Year |
---|---|
Preventing the second infarct.
Topics: Adult; Animals; Clinical Trials as Topic; Death, Sudden; Dogs; Electrocardiography; Exercise Therapy; Humans; Hyaluronoglucosaminidase; Middle Aged; Monitoring, Physiologic; Myocardial Infarction; Practolol; Recurrence; Smoking Prevention; Sulfinpyrazone | 1980 |
4 other study(ies) available for sulfinpyrazone and practolol
Article | Year |
---|---|
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mortality after recovery from myocardial infarction.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Death, Sudden; Heart Failure; Humans; Myocardial Infarction; Practolol; Risk; Sulfinpyrazone; Time Factors | 1980 |
Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart.
Topics: Animals; Coronary Disease; Dogs; Female; Heart; Heart Conduction System; Lidocaine; Male; Myocardial Contraction; Norepinephrine; Practolol; Refractory Period, Electrophysiological; Sulfinpyrazone; Ventricular Fibrillation | 1982 |